Health is Our Passion and Priority

Astellas Pharma US is focused on providing safe and effective products that improve people's lives. We are committed to making a difference for our patients today and providing them with a brighter future tomorrow.

This commitment extends to providing resources for our patients and their physicians and caregivers that help them throughout the life cycle of their condition and beyond.

Below is a list of Astellas' products marketed in the U.S. This information is intended for U.S. residents only.

View Astellas products for the global market on our global website.

Blindness & Regeneration

IZERVAYTM (avacincaptad pegol intravitreal solution)


Lexiscan® (regadenoson) injection


ASTAGRAF XL® (tacrolimus extended-release capsules)


Prograf® (tacrolimus) capsules, granules and injection

Infectious Disease

AmBisome® (amphotericin B) liposome for injection

CRESEMBA® (isavuconazonium sulfate)

MYCAMINE® (micafungin for injection) for intravenous use


XTANDI® (enzalutamide) capsules

XOSPATA® (gilteritinib) tablets

PADCEV® (enfortumab vedotin-ejfv)


Myrbetriq® (mirabegron extended-release tablets)

Myrbetriq® Granules (mirabegron for extended-release oral suspension)

VESIcare® (solifenacin succinate) tablets

VESIcare LS®  (solifenacin succinate) oral suspension

Women's Health

VEOZAH® (fezolinetant) tablets

This information is intended for U.S. residents only.

All trademarks are Astellas' except AmBisome is a registered trademark of Gilead Sciences, Inc.